Article Information
History
- December 7, 2023.
Article Versions
- Version 1 (August 2, 2023 - 19:31).
- Version 2 (October 5, 2023 - 07:43).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Miguel I. Paredes1,2,*,
- Nashwa Ahmed2,3,
- Marlin Figgins2,4,
- Vittoria Colizza5,
- Philippe Lemey6,
- John T. McCrone2,
- Nicola Müller2,
- Cécile Tran-Kiem2 and
- Trevor Bedford1,2,7
- 1Department of Epidemiology, University of Washington, Seattle, Washington, USA
- 2Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA
- 3Molecular and Cellular Biology Program, University of Washington, Seattle, WA, USA
- 4Department of Applied Mathematics, University of Washington, Seattle, WA, USA
- 5INSERM, Sorbonne Université, Institut Pierre Louis d’Epidémiologie et de Santé Publique IPLESP, Paris, France
- 6Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium
- 7Howard Hughes Medical Institute, Seattle, WA, USA
- ↵*Corresponding author. Email: paredesm{at}uw.edu
Posted December 07, 2023.
Early underdetected dissemination across countries followed by extensive local transmission propelled the 2022 mpox epidemic
